Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Nov 8, 2024. (Total: 233355Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 8 (of 8 Records)

Query Trace: Multiple Myeloma and CCND1[original query]
The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. GWAS Catalog
Nature genetics 2013 Mar .
Weinhold N, Johnson DC, Chubb D, Chen B, Försti A, Hosking FJ, Broderick P, Ma YP, Dobbins SE, Hose D, Walker BA, Davies FE, Kaiser MF, Li NL, Gregory WA, Jackson GH, Witzens-Harig M, Neben K, Hoffmann P, Nöthen MM, Mühleisen TW, Eisele L, Ross FM, Jauch A, Goldschmidt H, Houlston RS, Morgan GJ, Hemminki K
Cyclin D1 G870A polymorphism is associated with an increased risk of multiple myeloma.
Genetics and molecular research : GMR 2015 14 (2): 5856-61.
Wang S, Huang Y, Su R, Fang Z, Han
Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients.
Leukemia 2018 01 32 (1): 102-110.
Shah V, Sherborne A L, Walker B A, Johnson D C, Boyle E M, Ellis S, Begum D B, Proszek P Z, Jones J R, Pawlyn C, Savola S, Jenner M W, Drayson M T, Owen R G, Houlston R S, Cairns D A, Gregory W M, Cook G, Davies F E, Jackson G H, Morgan G J, Kaiser M
Mutational landscape reflects the biological continuum of plasma cell dyscrasias.
Blood cancer journal 2017 Feb 7 (2): e537.
Rossi A, Voigtlaender M, Janjetovic S, Thiele B, Alawi M, März M, Brandt A, Hansen T, Radloff J, Schön G, Hegenbart U, Schönland S, Langer C, Bokemeyer C, Binder
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.
Blood 2018 6 132 (6): 587-597.
Walker Brian A, Mavrommatis Konstantinos, Wardell Christopher P, Ashby T Cody, Bauer Michael, Davies Faith E, Rosenthal Adam, Wang Hongwei, Qu Pingping, Hoering Antje, Samur Mehmet, Towfic Fadi, Ortiz Maria, Flynt Erin, Yu Zhinuan, Yang Zhihong, Rozelle Dan, Obenauer John, Trotter Matthew, Auclair Daniel, Keats Jonathan, Bolli Niccolo, Fulciniti Mariateresa, Szalat Raphael, Moreau Philippe, Durie Brian, Stewart A Keith, Goldschmidt Hartmut, Raab Marc S, Einsele Hermann, Sonneveld Pieter, San Miguel Jesus, Lonial Sagar, Jackson Graham H, Anderson Kenneth C, Avet-Loiseau Herve, Munshi Nikhil, Thakurta Anjan, Morgan Gareth
The SLAMF3 rs509749 polymorphism correlates with malignant potential in multiple myeloma.
Experimental hematology 2020 Aug .
Ishibashi Mariko, Sunakawa-Kii Mika, Kaito Yuta, Kinoshita Ryosuke, Asayama Toshio, Kuribayashi Yasuko, Inokuchi Koiti, Morita Rimpei, Tamura Hide
The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma.
Cells 2023 4 12 (7): .
Szudy-Szczyrek Aneta, Mlak Rados?aw, Mazurek Marcin, Krajka Tomasz, Chocholska Sylwia, Bitkowska Paulina, Jutrzenka Marta, Szczyrek Micha?, Homa-Mlak Iwona, Krajka Andrzej, Ma?ecka-Massalska Teresa, Hus Mar
Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14).
Leukemia 2024 10 .
Hongwei Tang, Huihuang Yan, Suganti Shivaram, Stacey Lehman, Neeraj Sharma, James Smadbeck, Cinthya Zepeda-Mendoza, Shulan Tian, Yan Asmann, Celine Vachon, Alexandre Gaspar Maia, Jonathan Keats, P Leif Bergsagel, Rafael Fonseca, A Keith Stewart, Joel-Sean Hsu, Richard K Kandasamy, Akhilesh Pandey, Marcella A Kaddoura, Francesco Maura, Amit Mitra, S Vincent Rajkumar, Shaji K Kumar, Eran Elhaik, Esteban Braggio, Linda B Baug
TOP